Apogee Therapeutics, Inc. — Investor Relations & Filings
Apogee Therapeutics, Inc. is a clinical-stage biotechnology company that develops differentiated biologics for immunological and inflammatory (I&I) diseases. The company's pipeline consists of novel antibody therapeutics targeting well-established biological pathways to treat conditions such as atopic dermatitis (AD), asthma, and chronic obstructive pulmonary disease (COPD), as well as other dermatological and respiratory disorders. Apogee's scientific approach focuses on creating therapies with the potential for improved efficacy and less frequent dosing, aiming to advance the standard of care for patients with these conditions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 8-K | 2026-05-27 | English | |
| FORM 8-K | 2026-05-27 | English | |
| 10-Q - Apogee Therapeutics, Inc. (0001974640) (Filer) | 2026-05-11 | English | |
| 8-K - Apogee Therapeutics, Inc. (0001974640) (Filer) | 2026-05-11 | English | |
| ARS - Apogee Therapeutics, Inc. (0001974640) (Filer) | 2026-04-24 | English | |
| 4 - Apogee Therapeutics, Inc. (0001974640) (Issuer) | 2026-03-28 | English |
Browse filings by year
4 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
BridgeBio Oncology Therapeutics, Inc.
Clinical-stage biopharma developing inhibitors for genetica…
|
BBOT | US | Manufacturing |
|
BridgeBio Pharma, Inc.
Develops transformative medicines for genetic diseases and …
|
BBIO | US | Manufacturing |
|
Brightgene Bio-Medical Technology Co., Ltd.
Research-driven developer of complex APIs, high-end generic…
|
688166 | CN | Manufacturing |
|
BRIGHT MINDS BIOSCIENCES INC.
Develops selective serotonin agonists for neurological and …
|
DRUG | US | Manufacturing |
|
BrightPath Biotherapeutics Co., Ltd.
A clinical-stage biopharma company developing cancer immuno…
|
4594 | JP | Manufacturing |
|
Brii Biosciences Limited
Developing first-in-class therapies targeting infectious an…
|
2137 | KY | Manufacturing |
|
BRISTOL MYERS SQUIBB CO
A global biopharmaceutical company that discovers, develops…
|
BMY | US | Manufacturing |
|
BROOKS LABORATORIES LIMITED
Pharmaceutical manufacturer specializing in CRAMS and diver…
|
BROOKS | IN | Manufacturing |
|
BUKWANG PHARMACEUTICAL IND CO.,LTD
An R&D-focused company developing drugs for CNS disorders a…
|
003000 | KR | Manufacturing |
|
BY-HEALTH CO.,LTD
Researches, develops, and distributes dietary supplements, …
|
300146 | CN | Manufacturing |
Apogee Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31550/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31550 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31550 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31550 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31550}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Apogee Therapeutics, Inc. (id: 31550)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.